Khiron Life Sciences Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep '22 Sep 30, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	1.94	8.92	21.65	9.17	14.93	1.81
Short-Term Investments	-	-	-	27.56	3.95	-
Cash & Short-Term Investments	1.94	8.92	21.65	36.73	18.88	1.81
Cash Growth	-87.43%	-58.78%	-41.06%	94.53%	943.40%	-
Accounts Receivable	4.38	2.88	4.58	3.15	2.92	-
Other Receivables	0.16	-	-	1.09	1.25	0.29
Receivables	4.54	2.88	4.58	4.24	4.17	0.29
Inventory	9.81	9.45	8.34	0.96	0.24	-
Prepaid Expenses	2.04	2.52	1.85	0.9	0.56	0.56
Restricted Cash	-	-	-	0.17	0.08	-
Other Current Assets	-	-	-	1.8	-	-
Total Current Assets	18.33	23.77	36.42	44.81	23.93	2.65
Property, Plant & Equipment	13.15	13.56	17.52	15.86	9.62	0.24
Goodwill	6.11	4.08	4.11	4.35	4.64	-
Other Intangible Assets	0.87	0.87	15.13	15.55	2.01	0
Other Long-Term Assets	-	-	-	1.34	0.15	-
Total Assets	38.45	42.27	73.18	81.91	40.35	2.9
Accounts Payable	6.76	4.31	6.26	7.43	6.44	0.45
Accrued Expenses	-	-	-	-	-	0.05
Current Portion of Long-Term Debt	0.47	0.74	0.5	0.57	0.16	-
Current Portion of Leases	0.76	0.79	0.58	0.44	-	-
Other Current Liabilities	1.08	1.89	-	-	-	0.21
Total Current Liabilities	9.06	7.72	7.34	8.44	6.6	0.7
Long-Term Debt	0.35	-	-	-	1.13	-
Long-Term Leases	0.99	0.71	1.71	2.55	1.22	-
Long-Term Deferred Tax Liabilities	0.26	0.31	0.9	0.89	0.65	-
Other Long-Term Liabilities	0.69	0.21	-	-	5.21	-
Total Liabilities	11.35	8.95	9.95	11.87	14.81	0.7
Common Stock	151.87	146.45	137.08	121.29	39.83	4.29
Retained Earnings	-127.97	-116.81	-83.68	-59.96	-23.59	-3.78
Comprehensive Income & Other	3.21	3.69	9.83	8.71	9.3	1.68
Shareholders' Equity	27.1	33.33	63.23	70.04	25.54	2.19
Total Liabilities & Equity	38.45	42.27	73.18	81.91	40.35	2.9
Total Debt	2.56	2.23	2.79	3.55	2.51	-
Net Cash (Debt)	-0.63	6.7	18.86	33.18	16.37	1.81
Net Cash Growth	-	-64.49%	-43.16%	102.64%	804.77%	-
Net Cash Per Share	-0.00	0.04	0.16	0.33	0.34	0.07
Filing Date Shares Outstanding	216.39	179.67	150.72	116.1	92.07	32.57
Total Common Shares Outstanding	217.14	179.26	150.72	116.61	75.04	32.57
Working Capital	9.27	16.06	29.07	36.37	17.34	1.95
Book Value Per Share	0.12	0.19	0.42	0.60	0.34	0.07
Tangible Book Value	20.12	28.39	43.98	50.14	18.9	2.19
Tangible Book Value Per Share	0.09	0.16	0.29	0.43	0.25	0.07
Land	1.28	1.09	1.31	1.38	1.47	-
Buildings	8.59	9.29	11.28	8.92	6.99	-
Machinery	5.19	4.38	4.02	3.4	0.98	0.03
Construction In Progress	1.01	0.95	0.84	0.81	0.51	-
Leasehold Improvements	-	-	-	-	-	0.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.